Study Information
Locations
Clinical Trial FAQs
Information for patients and study volunteers, including frequently asked questions.
Description
Our project will enhance understanding of how cancer care is triaged, delivered, and how treatment plans are modified due to the impact of COVID-19.
Our project will inform the use of telemedicine in cancer care and variability by patient characteristics, which have the potential to reduce disparities in the delivery of telemedicine.
Our estimates on the volume of postponed services during COVID-19 pandemic can inform healthcare systems’ planning of future workflows as well as future studies evaluating the impact of delayed services on patient health outcomes.
John K. Chan, M.D., and Allison W. Kurian, M.D., MSc, are Clinical Advisors.
Principal Investigator
Co-Investigator(s)
Funder
UC Office of the President, Research Grants Program Office
Related Studies
Breast Cancer Chemoprevention in Primary Care at Geisinger
Investigators: Xiaowei (Sherry) Yan, PhD, MS, External PI, Principal Investigator
COVID-19 Impacts on Cancer Care Management, Patient Experience and Care Costs
Investigators: Cheryl Stults, Ph.D., Monique de Bruin, M.D., MPH, Su-Ying Liang, Ph.D.
Cancer Liquid Biopsy Monitoring Study
Investigators: Deepti Behl, MD, Mohammed Kashani-Sabet, M.D.
Coverage, Price, and Reimbursement for Multigene Tests for Cancer and Related Conditions
Investigator: Su-Ying Liang, Ph.D.
Implementing Universal Lynch Syndrome Screening Across Multiple Healthcare Systems: Identifying Strategies to Facilitate and Maintain Programs in Different Organizations Contexts
Investigators: Monique de Bruin, M.D., MPH, Su-Ying Liang, Ph.D., External PI, Principal Investigator
Improving Cancer Care
Investigators: Su-Ying Liang, Ph.D., Ellis C. Dillon, Ph.D.
Lung Cancer in Never Smokers: Incidence, Risk Factors and Molecular Characteristics in Asian American, Native Hawaiian, and Pacific Islander (AANHPI) Women
Investigators: Su-Ying Liang, Ph.D., External PI, Principal Investigator
Multilevel Study of Lung Cancer Screening Guidelines Implementation (MUST)
Investigator: Jiang Li, Ph.D., MPH
Stupski Serious Illness Program Evaluation
Investigators: Ellis C. Dillon, Ph.D., Sylvia Sudat, PhD